PATRICK FAGAN

CLEVELAND, OH

This page merges CMS profile IDs: 11419543, 7226375 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$755.48

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 43
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $348.04 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $348.0420

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $143.648
Lilly USA, LLC $83.905
UCB, Inc. $48.263
Alexion Pharmaceuticals, Inc. $25.201
ARGENX US, INC. $16.871
PFIZER INC. $16.191
Neurocrine BioSciences, Inc. $13.981

By program year

Program yearAmountRecords
2019 $49.413
2020 $55.343
2021 $31.742
2022 $128.117
2023 $142.848
2024 $348.0420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093993046 Alexion Pharmaceuticals, Inc. $25.20 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705383 ABBVIE INC. $3.75 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705385 ABBVIE INC. $25.40 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705387 ABBVIE INC. $20.56 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705389 ABBVIE INC. $32.23 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705391 ABBVIE INC. $7.03 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705393 ABBVIE INC. $15.12 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705395 ABBVIE INC. $31.43 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705397 ABBVIE INC. $8.12 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131217183 PFIZER INC. $16.19 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135263095 Lilly USA, LLC $16.22 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135277843 Lilly USA, LLC $15.22 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135279445 Lilly USA, LLC $18.19 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135308618 Lilly USA, LLC $18.80 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135317200 Lilly USA, LLC $15.47 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142122360 ARGENX US, INC. $16.87 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143336306 UCB, Inc. $17.02 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143336310 UCB, Inc. $15.11 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143336314 UCB, Inc. $16.13 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150877563 Neurocrine Biosciences, Inc. $13.98 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 11419543, 7226375

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.